Literature DB >> 15877901

The SYNCAN project: goals, set-up, first results and settings of the human intervention study.

Jan Van Loo1, Yvonne Clune, Mary Bennett, John Kevin Collins.   

Abstract

Experimental evidence on the anticancer properties of dietary prebiotics such as chicory inulin and oligofructose and dietary probiotics has accumulated in recent years. Various experimental models ranging from chemoprevention studies, tumour implantation models to genetically modified mice models, etc. have systematically shown the protective effects of these food ingredients. In some studies it appeared that synbiotics (combination of pre- and probiotics) exerted synergistic activity against processes of carcinogenesis. The logical next step in research was to find out if these observations also would be valid for human volunteers. This was the principal goal of the EU-sponsored SYNCAN project (QLK1-1999-346) which involved the integration of an in vitro study to select the most suitable synbiotic preparation, the application of this synbiotic in an in vivo rat model of chemically induced colon cancer, and, as the heart of the project, the investigation of the synbiotic effects in a human intervention study. The in vitro tests consisted of fermentation studies where the interaction of pre- and probiotics was studied. Cell-free supernatants were generated from various synbiotic combinations fermented by faecal slurry, which were then used to optimise a series of bioassays. In the rat study the anticarcinogenic effect of prebiotics and synbiotics but not of probiotics was demonstrated. Using tissue samples generated in this model, attempts were made to gain a better insight into the mechanisms underlying cancer development. The human intervention study consisted of two groups of volunteers. One group was composed of people at high risk (polypectomised subjects) for colon cancer and the other of volunteers (colon cancer subjects) who had previously undergone 'curative resection' for colon cancer but were not currently receiving treatment. The present paper describes the experimental design of the SYNCAN study, and demonstrates a functional effect of the synbiotic preparation (probiotic survival during gastrointestinal transit and modification of the intestinal flora). Detailed experimental outcome of the human intervention study will be reported elsewhere.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15877901     DOI: 10.1079/bjn20041353

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  6 in total

Review 1.  Obesity and gut-microbiota-brain axis: A narrative review.

Authors:  Arezoo Asadi; Negar Shadab Mehr; Mohamad Hosein Mohamadi; Fazlollah Shokri; Mohsen Heidary; Nourkhoda Sadeghifard; Saeed Khoshnood
Journal:  J Clin Lab Anal       Date:  2022-04-14       Impact factor: 3.124

Review 2.  Gut microbiome, gut function, and probiotics: Implications for health.

Authors:  Neerja Hajela; B S Ramakrishna; G Balakrish Nair; Philip Abraham; Sarath Gopalan; Nirmal K Ganguly
Journal:  Indian J Gastroenterol       Date:  2015-04-29

3.  Association of Dietary Prebiotic Consumption with Reduced Risk of Alzheimer's Disease in a Multiethnic Population.

Authors:  Mia Nishikawa; Adam M Brickman; Jennifer J Manly; Nicole Schupf; Richard P Mayeux; Yian Gu
Journal:  Curr Alzheimer Res       Date:  2021       Impact factor: 3.498

Review 4.  Effects of Probiotics, Prebiotics, and Synbiotics on Human Health.

Authors:  Paulina Markowiak; Katarzyna Śliżewska
Journal:  Nutrients       Date:  2017-09-15       Impact factor: 5.717

5.  Combinatorial Effects of Soluble, Insoluble, and Organic Extracts from Jerusalem Artichokes on Gut Microbiota in Mice.

Authors:  Hiroyuki Sasaki; Yijin Lyu; Yuki Nakayama; Fumiaki Nakamura; Aya Watanabe; Hiroki Miyakawa; Yoichi Nakao; Shigenobu Shibata
Journal:  Microorganisms       Date:  2020-06-24

Review 6.  Synbiotic Effects of Fermented Rice on Human Health and Wellness: A Natural Beverage That Boosts Immunity.

Authors:  Shivkanya Fuloria; Jyoti Mehta; Manash Pratim Talukdar; Mahendran Sekar; Siew Hua Gan; Vetriselvan Subramaniyan; Nur Najihah Izzati Mat Rani; M Yasmin Begum; Kumarappan Chidambaram; Rusli Nordin; Mohammad Nazmul Hasan Maziz; Kathiresan V Sathasivam; Pei Teng Lum; Neeraj Kumar Fuloria
Journal:  Front Microbiol       Date:  2022-07-13       Impact factor: 6.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.